Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Savara Inc (SVRA)

Savara Inc (SVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks Set to Open Higher as Investors Await U.S. Inflation Data

September S&P 500 E-Mini futures (ESU24) are up +0.74%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.95% this morning, partially rebounding from Friday’s losses driven by weaker-than-expected...

ESU24 : 5,699.99s (-0.31%)
NQU24 : 19,808.01s (-0.21%)
AVGO : 182.21 (+1.48%)
TSLA : 287.44 (-0.38%)
AMZN : 207.85 (+0.37%)
SMCI : 23.15 (+1.98%)
IOT : 50.34 (+0.16%)
ADBE : 507.52 (+0.53%)
ORCL : 181.50 (+0.14%)
KR : 59.73 (-0.11%)
GME : 23.10 (unch)
ADS.D.DX : 222.800 (+4.70%)
Why Shares of Savara Jumped on Tuesday

The company released first-quarter earnings and said it had completed a phase 3 trial enrollment for its lead therapy.

SVRA : 3.82 (+5.52%)
Savara Announces New Employment Inducement Grant

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees.

SVRA : 3.82 (+5.52%)
Savara Announces New Employment Inducement Grant

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees.

SVRA : 3.82 (+5.52%)
Savara Reports Fourth Quarter / Year-End 2022 Financial Results and Provides Business Update

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the fourth quarter and full year ending December 31, 2022 and...

SVRA : 3.82 (+5.52%)
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the Oppenheimer 33rd Annual Healthcare...

SVRA : 3.82 (+5.52%)
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to a new employee.

SVRA : 3.82 (+5.52%)
Savara Announces New Leadership Appointments

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the appointments of two pharmaceutical industry veterans to its executive leadership...

SVRA : 3.82 (+5.52%)
Why Shares of Savara Soared This Week

The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases.

SVRA : 3.82 (+5.52%)
Savara Announces New Employment Inducement Grant

Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to two new employees.

SVRA : 3.82 (+5.52%)

Barchart Exclusives

Is Now a Good Time to Buy Qualcomm Stock?
Qualcomm is poised to benefit from opportunities led by the shift toward on-device AI and its tech advancements in Handsets, PC, Automotive and Industrial Internet of Things (IoT). Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar